Marker Therapeutics, Inc. MRKR
Set alert
0.91 USD -0.07 -7.01%
As of Nov 2, 9:54 AM ET
0.8901 Day range 0.97
0.84 52-week range 2.46
- YTD
- -38.84%
- 1 year
- -7.95%
- Open
- 0.96
- Prev close
- 0.98
- Mkt cap
- 15.19M
- Vol
- 49.91K
- Avg vol
- 108.53K
- EPS
- -0.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8901
- High
- 0.97
- Forward P/E
- -2.34
- Beta
- 1.49
- Short ratio
- 1.55
- Inst. own
- 22.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 27, 2024
- 50-d avg
- 3.71
- 200-d avg
- 3.97
- 1y target
- 19.00
1M chart
Signals (8)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 36 minutes ago |
| MACD: Buy Signal | Oct 28, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 27, 2026 | 6 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
Key statistics
- Market cap
- 30.52M
- Enterprise value
- 19.59M
- Trailing P/E
- 0.00
- Forward P/E
- -2.34
- PEG ratio
- 0.00
- Price / sales
- 8.19
- Price / book
- 2.16
- EPS (TTM)
- -1.07
- Beta
- 1.49
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -278.22%
- Revenue (TTM)
- 3.73M
- Revenue growth
- 53.30%
- Free cash flow
- -7.40M
- Total cash
- 7.80M
- Total debt
- 0
- Return on equity
- -71.74%
- Shares outstanding
- 8.92M
- Short % of float
- 1.09%
- 50-day average
- 3.71
- 200-day average
- 3.97
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 19.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Mar 27, 2024
Expected Mar 27, 2024. Consensus EPS estimate -0.28.
Financials — quick view
MRKR Revenue — quarterly 0
MRKR Net income — quarterly -1.83M
MRKR EPS — quarterly -0.09
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.26 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.25 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -0.27 | — | — |
| Mar 27, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -0.34 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -0.47 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 30, 2024 | Ladenburg Thalmann | init | — | Buy |
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- markertherapeutics.com
News
- Marker Therapeutics Secures $2.6M From FDA Through Its Orphan Products Clinical Trials Grants Program To Support Phase 1 Clinical Study Evaluating Lead Investigational MAR-T Cell Therapy, MT-601, In Pancreatic Cancer
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Your note
Sign in to keep a note on MRKR — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| NEA Management Company, LLC | 12.01% | 1,071,428 | 3.66M | Sep 29, 2024 |
| Aisling Capital Management LP | 3.52% | 314,286 | 1.07M | Sep 29, 2024 |
| Vanguard Group Inc | 2.72% | 243,122 | 831.48K | Sep 29, 2024 |
| AR Asset Management, Inc. | 0.83% | 73,700 | 252.05K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.80% | 71,561 | 244.74K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.45% | 39,750 | 135.94K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.72% | 153,473 | 524.88K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.98% | 87,137 | 298.01K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.45% | 39,946 | 136.62K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.19% | 16,579 | 56.70K | Oct 30, 2024 |
| DFA U.S. Small Cap Series | 0.18% | 15,900 | 54.38K | Jul 30, 2024 |
| Fidelity Total Market Index Fund | 0.14% | 12,811 | 43.81K | Oct 30, 2024 |